Bioventus (BVS) Receivables (2020 - 2026)
Bioventus' (BVS) quarterly Receivables came in at $123.6 million in Q1 2026, up 2.21% YoY from $120.9 million in Q1 2025, and down 3.81% on a QoQ basis from $128.5 million in Q4 2025.
Bioventus (BVS) Receivables (2020 - 2026) Analysis & Trends
Bioventus (BVS) has 7 years of Receivables data on file, last reported at $123.6 million in Q1 2026.
- Quarterly Receivables rose 2.21% year-over-year to $123.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $123.6 million (up 2.21% YoY) and the FY2025 annual result came in at $128.5 million, up 0.79% from the prior year.
- Receivables fell to $123.6 million in Q1 2026, from $128.5 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $148.3 million in Q3 2022 to a low of $117.9 million in Q3 2023.
- A 5-year average of $128.8 million and a median of $128.5 million in 2025 frame the typical range for Receivables.
- Annual changes were most pronounced in 2022 — Receivables surged 45.36% — and 2023, when it decreased 19.33%.
- Tracing BVS's Receivables over 5 years: stood at $136.6 million in 2022, then dropped by 6.81% to $127.3 million in 2023, then advanced by 0.16% to $127.5 million in 2024, then advanced by 0.79% to $128.5 million in 2025, then slipped by 3.81% to $123.6 million in 2026.
- The last three Receivables figures came in at $123.6 million (Q1 2026), $128.5 million (Q4 2025), and $130.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 8.60 Bn |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 3.74 Bn |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 6.64 Bn |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 3.18 Bn |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 955.70 Mn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 1.28 Bn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 4.66 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 4.12 Bn |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 1.01 Bn |
| 10 | Bioventus | 966.46 Mn | 937.00 Mn | 105.67 Mn | 141.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 141.02 Mn |
| Mar 28, 2026 | 123.58 Mn |
| Dec 31, 2025 | 128.48 Mn |
| Sep 27, 2025 | 130.40 Mn |
| Jun 28, 2025 | 135.27 Mn |
| Mar 29, 2025 | 120.92 Mn |
| Dec 31, 2024 | 127.47 Mn |
| Sep 28, 2024 | 131.24 Mn |
| Jun 29, 2024 | 140.20 Mn |
| Mar 30, 2024 | 128.67 Mn |
| Dec 31, 2023 | 127.27 Mn |
| Sep 30, 2023 | 117.94 Mn |
| Jul 1, 2023 | 119.64 Mn |
| Apr 1, 2023 | 118.54 Mn |
| Dec 31, 2022 | 136.56 Mn |
| Oct 1, 2022 | 132.19 Mn |
| Jul 2, 2022 | 148.31 Mn |
| Apr 2, 2022 | 123.54 Mn |
| Dec 31, 2021 | 125.05 Mn |
| Oct 2, 2021 | 105.44 Mn |